Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

3D Tissue Grown from Stem Cells - New Model System for Brain Development

Published: Monday, September 02, 2013
Last Updated: Monday, September 02, 2013
Bookmark and Share
An international team of researchers has used stem cells to create a 3D structure that mimics early human brain development.

The group showed that these “cerebral organoids” can be used as a model system to analyse the origins of the human genetic disorder microcephaly, in which brain size is significantly reduced.
The research, led by Juergen Knoblich at the Institute of Molecular Biotechnology, Austria, in collaboration with scientists at the Medical Research Council (MRC) Human Genetics Unit at the University of Edinburgh, provides a unique new laboratory tool for studying human-specific features of brain development and neurological disorders in a way that has not been possible using animal models.

To create the brain tissue, the researchers developed a finely-tuned culture system that capitalises on stem cells’ innate ability to organise themselves into complex organ structures.

They began with human embryonic and induced pluripotent stem cells, which they used to produce neuroectoderm – the layer of cells in the embryo from which all components of the brain and nervous system develop. Fragments of this tissue were then embedded in gel droplets that provided a scaffold for complex tissue growth and placed into a spinning bioreactor. The circulation of culture media in the bioreactor improves oxygen and nutrient supply allowing the organoids to grow to a larger size.

After a month, the tissue fragments had organised themselves into primitive structures that could be recognised as developing brain regions such as retina, choroid plexus and cerebral cortex. At the microscopic level in the cortex, radial glial stem cells, pivotal in developing the central nervous system, were seen to generate neurons in an identical manner to that known to occur in normal development. At two months, the organoids had reached their maximum size of 4mm, but they lacked the more detailed organisational structure of a fully developed brain.

Using patient induced pluripotent stem cells, the researchers were able to model the development of microcephaly, a disorder that has proved difficult to reproduce in mice. As expected, the organoids created using these cells grew to a smaller size.
 
On further investigation, they found that genetic mutations in these patients results in an earlier than normal switch in neural stem cells from self-renewal (making copies of themselves) to differentiation into nerve cells, leading to an overall reduction in cell number and size of the organoid.

Dr Andrew Jackson from the MRC Human Genetics Unit at the University of Edinburgh, a medical geneticist who studies neurological disorders and a co-author of the paper, said:

“The human brain is one of the most complex biological structures known to man. This level of complexity isn’t present in model animals such as mice, and so the organoid cell culture system gives us an exciting new way of studying the early events of brain development in tissue culture to learn more about neurodevelopmental disorders such as microcephaly.

“Our colleagues in Austria have made an amazing achievement in developing a 3D culture system that gives us a means of realistically modelling the complex interaction of multiple cell types in early human brain development. Being able to generate tissue with such complexity in cell culture is a significant advance for the study of human disease in the lab.”

Dr Paul Colville Nash, MRC Programme Manager in stem cell and developmental biology, said:

“This is a fascinating piece of research that demonstrates the remarkable potential of using stem cells to develop model systems in order to give us new insights into human development and disease. Model systems like these are likely to become increasingly important for early testing of new therapies before they progress to human trials.”

The research was led by Dr Jeurgen Knoblich at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences and Dr Madeline A Lancaster was first author of the study. Dr Jackson’s team provided microcephaly patient cells and expertise on microcephaly disorders to the study.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Wednesday, July 22, 2015
‘Mini Bile Ducts’ used to Discover New Drugs that could Prevent Liver Damage
An experimental cystic fibrosis drug has been shown to prevent the disease’s damage to the liver, thanks to a world-first where scientists grew mini bile ducts in the lab.
Tuesday, July 14, 2015
£25m to Kick-Start ‘Industrial Revolution’ in Regenerative Medicine
Applications will include Parkinson’s disease, cardiovascular disease, wound and musculoskeletal repair, eye disorders and deafness.
Wednesday, September 11, 2013
New Type of Blood Stem Cell Could Help Solve Platelet Shortage
Scientists have identified a new type of bone marrow stem cell in mice that is primed to produce large numbers of vital blood-clotting platelets.
Tuesday, August 13, 2013
£93 Million Package of Support Announced for UK’s Health Industries
Innovative business and academic projects will benefit from a new £93.2 million package of support.
Wednesday, July 31, 2013
Scientists Transplant Photoreceptors from Retina Grown ‘in a Dish’
Scientists have carried out the first successful transplant of light-sensitive photoreceptor cells taken from a synthetic retina, grown ‘in a dish’ from embryonic stem cells.
Tuesday, July 23, 2013
£20m Boost for UK Regenerative Medicine
The MRC and British Heart Foundation (BHF) announced £20m of funding to boost the development of regenerative medicine therapies.
Thursday, April 11, 2013
Human Brain Research Made Easier by Database
Researchers will be able to access samples from more than 7,000 donated human brains to help study major brain diseases, thanks to a new on-line database, launched by the MRC.
Thursday, March 21, 2013
MRC Delivering on the Life Sciences Strategy, One Year On
The Medical Research Council has made significant progress in implementing the measures outlined in last year’s Strategy for UK Life Sciences, according to a progress update published by the Government.
Tuesday, December 11, 2012
Stem Cells Created from Patient’s Own Blood
Scientists have discovered a patient-friendly and efficient way to make stem cells out of blood, increasing the hope that scientists could one day use stem cells made from patients’ own cells to treat cardiovascular disease.
Tuesday, December 04, 2012
First Randomised Controlled Trial to Show Spinal Cord Regeneration in Dogs
Medical Research Council researchers have shown it is possible to restore co-ordinated limb movement in dogs with severe spinal cord injury (SCI).
Monday, November 19, 2012
International Collaboration Brings Stem Cell Clinical Trials a Step Closer
Funding for two ambitious projects aimed at bringing stem cell treatments to the point of clinical trial has been unveiled by the Medical Research Council (MRC) today.
Friday, October 30, 2009
Setting the Record Straight: Hybrid Embryo Research
The Medical Research Council (MRC) sets the record straight following concerns about the level of investment in hybrid stem cell research, raised on the front page of today’s Independent.
Tuesday, October 06, 2009
MRC welcomes new blueprint for life sciences
A new Blueprint to put innovation at the heart of healthcare delivery in the UK has been launched by Lord Drayson and Lord Darzi at Imperial College London.
Wednesday, July 15, 2009
Virus-free Pluripotency for Human Cells
Scientists have paved the way for stem cells made from skin cells to be safely transplanted into humans – by overcoming one of the main health risks associated with previous techniques.
Monday, March 02, 2009
Scientific News
Improving Regenerative Medicine
Lab-created stem cells may lack key characteristics, UCLA research finds.
Muscles on-a-Chip
This study may help explain why stem cell-based therapies have so far shown limited benefits for heart attack patients in clinical trials.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cat Stem Cell Therapy Gives Humans Hope
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives.
Bile Acid Supports Production of Blood Stem Cells
A research group at Lund University has been able to show that bile acid is transferred from the mother to the foetus via the placenta to enable the foetus to produce blood stem cells.
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Edited Stem Cells Offer Hope of Precision Therapy for Blindness
Findings raise the possibility of treating blinding eye diseases using a patient's own corrected cells as replacement tissue.
Hacking the Programs of Cancer Stem Cells
All tumor cells are the offspring of a single, aberrant cell, but they are not all alike.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!